33
Participants
Start Date
February 29, 2008
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
Lenalidomide
10 mg daily given for 12 months
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Celgene Corporation
INDUSTRY
M.D. Anderson Cancer Center
OTHER